References
- Folkman J., Weisz P. Control of angiogenesis in biocatalysis and biometrics. J. Burrington, D. Clark. ACS Symposium Series, American Chemical Society, Washington, DC 1989; Vol. 392: 19–32
- Yen L., You X., Al Moustafa A., Batist G., Hynes N., Mader S., Meloche S., Alaoui-Jamal M. Heregulin selectively uperregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis. Oncogene 2000; 19: 3460–3469
- Growdon J., Fiuk St. Paralysis and movement disorders. Harrisson's Principles of Internal Medicine, J. Wilson, et al. MacGraw Hill Inc., New York 1991; 157–168
- Goldin A., Sofina Z., Syrkin A. Experimental evaluation of antitumor drugs in the USA and USSR and clinical corrections. Natl. Cancer Inst. Monogr. 1980; 55: 25–26
- Nelson R., Brilay S., Vaz O., Abcakian N. The effect of vagotomy and pyloroplasticity on colorectal tumor induction in rat. J. Surg. Oncol. 1992; 51: 281–286
- Sleeman M., Anderson K., Lambert P., Yancopoulos G., Wiegand S. The ciliary neurotrophic factor and its receptor, CNTFR alpha. Pharm. Acta Helv. 2000; 74: 265–272
- Xie F., Latalladi G., Kupffler D. Neurotrophic influence of sciatic nerve-released factors on isolated adult motoneurons in vitro. J. Peripher. Nerv. Syst. 1998; 3: 37–46
- He X., Yang F., Xie Z., Lu B. Intracellular Ca (2 +) and Ca (2 +)/calmodulin-dependent kinase II mediate acute potentiation of neurotransmitter release by neurotrophin-3. J. Cell Biol., 15: 783–792
- Helgren M., Squinto H., Davis D., Parry T., Bolton C., Heck Y., Zhu G. Trophic effect of ciliary neurotrophic factor on denervated skeletal muscle. Cell 1994; 76: 493–504
- Liovera M., Garcia-Marinez C., Lopez-Soriano J., Carbo N., Agell N., Lopez-Soriano F., Argiles J. Role of TNF receptor-1 in protein turnover during cancer cachexia using gene knockout mice. Mol. Cell. Endocrinol. 1998; 142: 183–189
- Weinstein E., Leder P. The extracellular region of heregulin is sufficient to promote mammary gland proliferation and tumorigenesis but not apoptosis. Cancer Res. 2000; 60: 3856–3861
- Holmgren L., O'Reilly M., Folkman J. Dormancy of micrometastases. Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med. 1995; 1: 149–153
- Hanahan D., Folkman J. Patterns and emerging mechanisms during tumorgenesis. Cell 1996; 86: 353–364
- Cross M., Claesson-Welsh L. FGF and VEGF function in angiogenesis. Trends Pharmacol. Sci. 2001; 22: 201–207
- Kondo M., Kiupara K., Togari A. Anti-apoptotic action of nerve growth factor in mouse osteoblastic cell line. Life Sci. 2000; 67: 1197–1206